News & Updates

Addition of sintilimab to pemetrexed and platinum-based chemotherapy maintained or improved health-related quality of life (HRQoL) and symptoms compared with chemotherapy alone in first-line (1L) treatment of locally advanced or metastatic non-squamous non-small-cell lung cancer (NSCLC), according to a prespecified exploratory analysis of the phase III ORIENT-11 trial.

Short-course vaginal cuff brachytherapy (VCB) is just as efficacious as standard regimens for adjuvant treatment of endometrial cancer, yielding noninferior patient-reported outcomes without compromising disease control while having acceptable toxicity, according to the phase III, unblinded, multicentre SAVE trial.